Login

Switch On Your HIV Smarts.

FDA Approves Truvada for PrEP

FDA Approves Truvada for PrEP

, by Reilly O'Neal

See why this new HIV prevention tool is both essential and controversial—and why there's still work to do around PrEP. Read More

Ask a Lawyer: The Affordable Care Act Survives—What Now?

Ask a Lawyer: The Affordable Care Act Survives—What Now?

, by Ari Ezra Waldman

Law professor Ari Ezra Waldman dissects the Supreme Court's decision on the Affordable Care Act, and what it means for people with HIV. Read More

Dolutegravir Looks Good in Another Advanced Clinical Trial

Dolutegravir Looks Good in Another Advanced Clinical Trial

, by Reilly O'Neal

Learn more about this next-generation integrase inhibitor and see how it stacks up against popular HIV drug regimen Atripla. Read More

Reducing Inflammation: Do Some HIV Drugs Work Better Than Others?

Reducing Inflammation: Do Some HIV Drugs Work Better Than Others?

, by San Francisco AIDS Foundation

New research suggests starting antiretroviral treatment reduces inflammation caused by HIV infection—but plenty of questions remain. Read More

AIDS 2012: D.C. Declaration Maps Route to Ending AIDS

AIDS 2012: D.C. Declaration Maps Route to Ending AIDS

, by Reilly O'Neal

“The goal of beginning to end the AIDS epidemic is ambitious, but achievable. It is within our grasp.” Learn about a new call to action for everyone working to end HIV/AIDS. Read More